HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CF PHARMTECH

30.340

+0.0400.13%

Volume:220.50K

Turnover:6.67M

Market Cap:12.50B

PE:487.34

High:30.640

Open:30.080

Low:29.780

Close:30.300

52wk High:48.800

52wk Low:27.200

Shares:411.98M

HK Float Shares:302.22M

Volume Ratio:1.04

T/O Rate:0.07%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.062

ROE:-5.62%

ROA:-5.30%

PB:11.91

PE(LYR):487.33

PS:18.91

Loading ...

Overview Company News Filings

CF PharmTech, Inc. (2652) Announces Proposed Adoption of 2025 H Share Award Scheme

Bulletin Express

CF PharmTech (2652) Announces Proposed Share Repurchase Mandate

Bulletin Express

CF PharmTech Inc. to Seek Shareholder Approval for H Share Award Scheme and Board Authorization at Upcoming Meeting

November 2025 Hong Kong Stock Market Investment Strategy and Top 10 Stock Picks

Hong Kong Stocks Movement | CF PHARMTECH (02652) Rises Nearly 3% as Company Completes First Enrollment for Emphysema Treatment

CF PHARMTECH Surges on Listing Debut Before Pullback: What Concerns Lurk Behind the Massive Oversubscription?

CF PharmTech Soars 219% in Hong Kong Trading Debut

MT Newswires Live

Hong Kong Stocks Open Lower: Hang Seng Down 0.21%, Tech Index Falls 0.11%, Tech Stocks Weaken While Gold Stocks Rise Broadly, CF PHARMTECH Surges Over 218% on Debut

Stock Track | CF PHARMTECH Skyrockets 218% in Hong Kong IPO Debut, Opening at HK$47 vs HK$14.75 Offer Price

Shares of CF Pharmtech Set to Open at HK$47 Each in Hong Kong Debut VS Offer Price HK$14.75 Apiece

THOMSON REUTERS

CF PharmTech Nets HK$525 Million from Hong Kong IPO Ahead of Trading Debut

MT Newswires Live

Chinese Drugmaker CF PharmTech Surges 101% in Hong Kong Grey Market

Tiger Newspress

IPO Margin Financing Statistics | September 29

IPO Margin Statistics | September 26

Hong Kong Stocks End Week in Red Amid New Tariffs; CF PharmTech Launches Hong Kong IPO

MT Newswires Live

BRIEF-CF PharmTech Launches Global Offering Of 41.2 Mln H Shares

CF PHARMTECH to Launch IPO from September 26 to October 2, Plans Global Offering of 41.198 Million H Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02652/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"CF PHARMTECH","latestPrice":30.34,"timestamp":1763021314359,"preClose":30.3,"halted":0,"volume":220500,"delay":0,"floatShares":302223586,"shares":411978387,"eps":0.0622565829027019,"marketStatus":"Not Yet Opened","change":0.04,"latestTime":"11-13 16:08:34","open":30.08,"high":30.64,"low":29.78,"amount":6672500,"amplitude":0.028383,"askPrice":30.48,"askSize":1000,"bidPrice":30.34,"bidSize":500,"shortable":0,"etf":0,"ttmEps":0.08192727240513803,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1763083800000},"marketStatusCode":0,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":30.3,"openAndCloseTimeList":[[1762997400000,1763006400000],[1763010000000,1763020800000]],"volumeRatio":1.0420604918381107,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":302223586,"roa":"-5.30%","roe":"-5.62%","lyrEps":0.062257,"volumeRatio":1.0420604918381107,"shares":411978387,"dividePrice":0,"high":30.64,"amplitude":0.028383,"preClose":30.3,"low":29.78,"week52Low":27.2,"pbRate":"11.91","psRate":"18.91","week52High":48.8,"institutionHeld":0,"latestPrice":30.34,"committee":-0.333333,"eps":0.0622565829027019,"divideRate":0,"volume":220500,"delay":0,"ttmEps":0.08192727240513803,"open":30.08,"prevYearClose":14.75,"prevWeekClose":28,"prevMonthClose":30.3,"prevQuarterClose":14.75,"fiveDayClose":29.46,"twentyDayClose":28.7,"sixtyDayClose":14.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2025-11-13","current":370.328452,"percent":0.76,"low":-293.764894,"twenty":386.814037,"median":398.53059,"eighty":411.572519,"high":450.433063,"avg":373.779582,"sd":134.340121,"marketCap":12499424261},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-13","current":411.273773,"twenty":386.814037,"median":398.53059,"eighty":411.572519,"marketCap":12499424261}],"updateTime":1763079590958},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1193664454","title":"CF PharmTech, Inc. (2652) Announces Proposed Adoption of 2025 H Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1193664454","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193664454?lang=en_us&edition=fundamental","pubTime":"2025-11-13 07:25","pubTimestamp":1762989905,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (長風藥業股份有限公司) (Stock Code: 2652) has resolved to propose the adoption of its 2025 H Share Award Scheme, seeking to enhance employee and management engagement by aligning their...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"1185409685","title":"CF PharmTech (2652) Announces Proposed Share Repurchase Mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=1185409685","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185409685?lang=en_us&edition=fundamental","pubTime":"2025-11-13 07:21","pubTimestamp":1762989702,"startTime":"0","endTime":"0","summary":"On November 13, 2025, CF PharmTech, Inc. (2652) announced that the Board of Directors approved a resolution to grant a general mandate for repurchase of its issued H shares listed on the Main Board...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"2583812195","title":"CF PharmTech Inc. to Seek Shareholder Approval for H Share Award Scheme and Board Authorization at Upcoming Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2583812195","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583812195?lang=en_us&edition=fundamental","pubTime":"2025-11-13 07:07","pubTimestamp":1762988850,"startTime":"0","endTime":"0","summary":"CF PharmTech Inc. has announced a proxy proposal for shareholder approval at its upcoming general meeting. The proposal seeks to adopt the 2025 H Share Award Scheme and authorize the Board and/or an authorized person to handle all matters relating to the scheme. The H Share Award Scheme is designed to attract, retain, and motivate key talent by aligning employee and shareholder interests. The shareholder meeting to vote on this proposal will be held in the future, with details to be provided in a forthcoming circular. Shareholders are encouraged to vote in favor of the proposal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief on November 13, 2025, and is s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL4ckJmD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"1162918948","title":"November 2025 Hong Kong Stock Market Investment Strategy and Top 10 Stock Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=1162918948","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162918948?lang=en_us&edition=fundamental","pubTime":"2025-11-02 19:34","pubTimestamp":1762083279,"startTime":"0","endTime":"0","summary":"The Hong Kong stock market underperformed in October, with the Hang Seng Index briefly rising at the start of the month before retreating to its 60-day moving average. The index fluctuated between...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B031J352.USD","BK1166","BK1123","BK1583","BK1594","BK1524","LU1813983027.USD","03692","LU1282649067.USD","IE00BMCWC346.EUR","LU0821914370.USD","BK1514","BK1568","LU1282649810.SGD","00670","01138","BK1109","BK1506","LU0488056044.USD","LU0417516571.SGD","03898","BK1589","SG9999001051.SGD","IE0008368742.USD","LU0211977185.USD","BK1554","BK1505","BK4551","BK1129","IE00BVYPNP33.GBP","LU0149534421.HKD","LU1188198961.HKD","BK1191","BK4576","LU0244354667.USD","LU0348783233.USD","01635","BK1141","BK1227","BK1221","IE00BZ08YR35.GBP","01384","LU0359202008.SGD","BK1587","BK1163","BK1521","09696","BK1614","LU0348784397.USD","LU0173614495.USD","BK1116","LU1023057109.AUD","LU1328615791.USD","LU0607220059.USD","00027","LU1048596156.SGD","BK1186","IE0034224299.USD","BK1565","SG9999014674.SGD","IE00BZ08YT58.USD","01157","BK1535","BK4554","BK1095","LU0181495838.USD","LU2097828631.EUR","LU0314109678.HKD","LU0702159699.USD","LU2039709279.SGD","IE00B29SXG58.USD","08549","BK1169","IE00BGHQDM52.EUR","LU0650527681.SGD","IE0031814852.USD","IE0032431581.USD","SG9999001093.SGD","06682","BK1539","IE00BVYPNQ40.USD","SG9999001069.SGD","02382","BK1513","SG9999003461.SGD","LU0737861699.HKD","SGXZ90724238.SGD","BK1610","IE00B031HY20.USD","IE00BPRC5H50.USD","02600","BK1104","LU2045819591.USD","03877","BK1171","BK1615","BK1575","LU2097828474.EUR","LU1224709979.USD","LU2097828557.USD","LU1102505929.USD","BK1175","00826","BK1170","LU0463099449.HKD","LU0594300179.USD","LU1211504680.USD","LU0307460666.USD","SG9999002950.SGD","BK1548","LU2125910500.SGD","01618","LU1831875114.USD","02652","LU0140636845.USD","LU1166156734.SGD","02313","BK1608","SG9999006597.SGD","09626","BK1172","09880","BK1119","03759","LU0593848301.USD","BK1183","LU1102505762.USD","LU0588546209.SGD","BK4077","IE00BYV24P56.USD","LU0828237940.HKD","IE0008369823.USD","BK1588","IE00BZ08YS42.EUR","LU0287142896.SGD","BK1148","02533","LU0594300419.USD","LU0384037296.USD","01385","01164","BK4508","BK1561","BK1178","BK1576","IE00B5MMRT66.SGD","03800","09868","00631","LU0359201612.USD","LU1880383366.USD","BK1504","LU0326950275.SGD","BK1613","LU2097828714.EUR","LU0605514214.HKD","BK1225","LU2097828805.USD","01888","CIF","SNAP","BK1592","01277","LU1328277881.USD","IE00B543WZ88.USD","BK1618"],"gpt_icon":1},{"id":"1125142676","title":"Hong Kong Stocks Movement | CF PHARMTECH (02652) Rises Nearly 3% as Company Completes First Enrollment for Emphysema Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1125142676","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125142676?lang=en_us&edition=fundamental","pubTime":"2025-10-17 11:54","pubTimestamp":1760673251,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) saw a nearly 3% increase this morning, with a current rise of 2.74%, trading at HKD 29.20 and a transaction volume of HKD 5.3645 million. According to official news from CF...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"1120961880","title":"CF PHARMTECH Surges on Listing Debut Before Pullback: What Concerns Lurk Behind the Massive Oversubscription?","url":"https://stock-news.laohu8.com/highlight/detail?id=1120961880","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120961880?lang=en_us&edition=fundamental","pubTime":"2025-10-09 13:52","pubTimestamp":1759989132,"startTime":"0","endTime":"0","summary":"The domestic inhaled formulation market has long been monopolized by multinational pharmaceutical companies, but CF PHARMTECH has successfully cracked open this market after eighteen years of effort....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":1},{"id":"2573138699","title":"CF PharmTech Soars 219% in Hong Kong Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2573138699","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573138699?lang=en_us&edition=fundamental","pubTime":"2025-10-08 09:55","pubTimestamp":1759888500,"startTime":"0","endTime":"0","summary":"CF PharmTech's (HKG:2652) shares opened 218.6% above the IPO price in a stellar Hong Kong debut on Wednesday morning.The inhalation drug developer opened at HK$47.00 per share, compared with the IPO price of HK$14.75.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4093","CF","02652","BK4588"],"gpt_icon":0},{"id":"1145245804","title":"Hong Kong Stocks Open Lower: Hang Seng Down 0.21%, Tech Index Falls 0.11%, Tech Stocks Weaken While Gold Stocks Rise Broadly, CF PHARMTECH Surges Over 218% on Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1145245804","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145245804?lang=en_us&edition=fundamental","pubTime":"2025-10-08 09:40","pubTimestamp":1759887649,"startTime":"0","endTime":"0","summary":"The US government shutdown has entered its second week, with import/export and trade balance data originally scheduled for Tuesday being delayed. Market participants expect that the military payroll...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"817803f49aa9435c21f99f0f245d4c72","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSImain","513600","BK4614","HSTECH","MCHmain","MHImain","02652","159562","HHImain","YANG","HSI","02833"],"gpt_icon":1},{"id":"1162083479","title":"Stock Track | CF PHARMTECH Skyrockets 218% in Hong Kong IPO Debut, Opening at HK$47 vs HK$14.75 Offer Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1162083479","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162083479?lang=en_us&edition=fundamental","pubTime":"2025-10-08 09:32","pubTimestamp":1759887163,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (HKG:2652) saw its stock price soar by an astounding 218.64% in its trading debut on the Hong Kong Stock Exchange. The inhalation drug developer's shares opened at HK$47 each, marking a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1676c02b8c84db744237cddfcf0ec9c5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02652"],"gpt_icon":1},{"id":"2573918589","title":"Shares of CF Pharmtech  Set to Open at HK$47 Each in Hong Kong Debut VS Offer Price HK$14.75 Apiece","url":"https://stock-news.laohu8.com/highlight/detail?id=2573918589","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573918589?lang=en_us&edition=fundamental","pubTime":"2025-10-08 09:20","pubTimestamp":1759886415,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"1676c02b8c84db744237cddfcf0ec9c5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nL3N3VP02E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02652"],"gpt_icon":0},{"id":"2573994235","title":"CF PharmTech Nets HK$525 Million from Hong Kong IPO Ahead of Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2573994235","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573994235?lang=en_us&edition=fundamental","pubTime":"2025-10-08 07:12","pubTimestamp":1759878742,"startTime":"0","endTime":"0","summary":"CF PharmTech  raised HK$525.4 million in net proceeds from its initial public offering in Hong Kong.The inhalation drug developer set the final offer price of its offering of 41,198,000 shares at HK$14.75 per share, according to a late Monday filing with the Hong Kong bourse.The Hong Kong public offering was 6,697.80 times oversubscribed, and the company offered 4,120,000 shares, the same number of shares initially allotted.The international offering was 12.74 times subscribed, with the final share allocation maintained at 37,078,000 shares.CF PharmTech will make its trading debut on the bourse today, Oct. 8.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CF","02652","BK4093","BK4585","BK4588"],"gpt_icon":1},{"id":"1197967782","title":"Chinese Drugmaker CF PharmTech Surges 101% in Hong Kong Grey Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1197967782","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197967782?lang=en_us&edition=fundamental","pubTime":"2025-10-06 16:16","pubTimestamp":1759738596,"startTime":"0","endTime":"0","summary":"Pharmaceutical manufacturer $CF PharmTech(02652)$ surged 100.8% in Hong Kong grey market.CF PharmTech reported revenue of nearly 610 million yuan last year, up 9% year-on-year. Its profit for the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"aca566adf5b00ee0a013aedcf9197dda","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"1142440414","title":"IPO Margin Financing Statistics | September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1142440414","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142440414?lang=en_us&edition=fundamental","pubTime":"2025-09-29 18:40","pubTimestamp":1759142426,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) is currently in its IPO process. As of September 29, brokers including Futu, Phillip Securities, and Sincere Securities have collectively provided margin financing of HK$82.0086 billion for CF PHARMTECH, representing an oversubscription of more than 1343 times.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK4023","BK4613","IE00BZ9MQY76.HKD","BK4608","IE00B19Z9Z06.USD","APP","BK4539","BK4588","IE00B19Z9P08.USD","LU0097036916.USD","IE00B894F039.SGD","BK4585"],"gpt_icon":0},{"id":"1169215989","title":"IPO Margin Statistics | September 26","url":"https://stock-news.laohu8.com/highlight/detail?id=1169215989","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169215989?lang=en_us&edition=fundamental","pubTime":"2025-09-26 18:50","pubTimestamp":1758883824,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) is currently in its IPO process. As of September 26, brokers including Futu, Phillip Securities, and Sincere Securities have collectively provided HK$968.97 million in margin financing for CF PHARMTECH, representing an oversubscription of more than 14.8 times.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK4023","BK4613","IE00BZ9MQY76.HKD","BK4608","IE00B19Z9Z06.USD","APP","BK4539","BK4588","IE00B19Z9P08.USD","LU0097036916.USD","IE00B894F039.SGD","BK4585"],"gpt_icon":0},{"id":"2570003336","title":"Hong Kong Stocks End Week in Red Amid New Tariffs; CF PharmTech Launches Hong Kong IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2570003336","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570003336?lang=en_us&edition=fundamental","pubTime":"2025-09-26 16:35","pubTimestamp":1758875711,"startTime":"0","endTime":"0","summary":"Hong Kong stocks ended the week in red as US President Donald Trump announced a new slate of tariffs on pharmaceutical goods and as markets followed trade updates.The Hang Seng Index fell by 356.48 po","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02833","HSI","CF","MHImain","MCHmain","BK1109","BK4093","BK4585","HHImain","BK4588","02652","513600"],"gpt_icon":1},{"id":"2570021163","title":"BRIEF-CF PharmTech Launches Global Offering Of 41.2 Mln H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2570021163","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570021163?lang=en_us&edition=fundamental","pubTime":"2025-09-26 09:40","pubTimestamp":1758850837,"startTime":"0","endTime":"0","summary":"BRIEF-CF PharmTech Launches Global Offering Of 41.2 Mln H SharesSept 26  - CF PharmTech 2652.HK:GLOBAL OFFERING OF 41.2 MILLION H SHARESOFFER PRICE OF HK$14.75 PER H SHARE UNDER GLOBAL OFFERINGNUMBER OF HONG KONG OFFER SHARES 4.1 MILLION H SHARES UNDER GLOBAL OFFERINGFurther company coverage: [ ] ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nFWN3VC18C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"1150655171","title":"CF PHARMTECH to Launch IPO from September 26 to October 2, Plans Global Offering of 41.198 Million H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1150655171","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150655171?lang=en_us&edition=fundamental","pubTime":"2025-09-26 08:30","pubTimestamp":1758846627,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) will conduct its initial public offering from September 26 to October 2, 2025, with plans to globally offer 41.198 million H shares. The distribution will comprise 10% for Hong...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}]}}